Dec. 23, 2021
.
melanie.hunter
The White House COVID-19 response team announced Wednesday that it has ordered more than 1 million treatment courses of GlaxoSmithKline’s monoclonal antibody treatment after discovering that two out of the three monoclonal antibody treatments are ineffective against the Omicron variant. Read Full Story
You might also like
Donate to uncover the truth
Make a difference and support the Media Research Center